We won’t stop until we’ve eradicated HIV/AIDS
ARA Chosen for Major Phase I Study
AIDS Research Alliance is pleased to announce that it will serve as an investigative site for a new Phase I Interaction Study examining interactions between HIV treatment Isentress (Raltegravir) and over-the-counter (OTC) antacids.
Isentress, approved by the FDA in 2007, is the only drug in its class of integrase inhibitors. Integrase inhibitors are a class of antiretroviral drug designed to block the action of integrase, a viral enzyme that inserts the viral genome into the DNA...
Read More
HVTN Update from Washington D.C.
Members of our Community Education and Recruitment team—Caleigh Douglass and James Aboagye, along with our Medical Director, Dr. Stephen Brown, attended the HIV Vaccine Trials Network (HVTN) Full Group Meeting in Washington, D.C. earlier this month.
At the conference, staff from the U.S. and global HVTN sites gathered to discuss progress being made in HIV vaccine research, as well as outreach strategies for recruiting trial volunteers.
Read More
5 Father’s Day Gifts that Give Back
Looking for a great Father’s Day gift? We’ve put together a gift guide for every type of dad – from the “Golf Pro” to the “Gadget Guy.” The best part of all is that each purchase earns AIDS Research Alliance a donation—at no extra charge to you.
Read More
HIV Vaccine No Less Urgent Because of Truvada
Last week, FDA advisers recommended approval of the drug Truvada to prevent HIV transmission. This is, in many respects, a momentous step in the fight on HIV/AIDS. But Truvada’s approval would not diminish the pressing need for an HIV vaccine.
Truvada has been shown to reduce risk of infection by up to 42%* in gay and bisexual men, and up to 75% in heterosexual couples where one partner is HIV-positive.
Read More
ARA Earns Permanent Spot on GlobalGiving
Thanks to you, ARA now holds a permanent spot on GlobalGiving, the international fundraising platform.
On April 1st, 2012, AIDS Research Alliance entered the GlobalGiving Challenge, seeking to earn a permanent spot on this internationally recognized fundraising platform. The terms of the challenge were to raise $4,000 from 50 unique donors within 30 days.
Over the course of the month, we reached out to you by email, on Facebook, and on Twitter. And you gave us your support. As of April 30th, we now hold a permanent spot on GlobalGiving. In fact, we ranked...
Read More